141 related articles for article (PubMed ID: 7908219)
21. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
Chang H; Blondal JA; Benchimol S; Minden MD; Messner HA
Leuk Lymphoma; 1995 Sep; 19(1-2):165-71. PubMed ID: 8574164
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.
Cunningham LM; Chapman C; Dunstan R; Bell MC; Joske DJ
Leuk Lymphoma; 2003 Feb; 44(2):251-5. PubMed ID: 12688341
[TBL] [Abstract][Full Text] [Related]
23. The associations of HLA-A, -B, DRB1 alleles and haplotypes in Turkish lymphoma patients.
Uçar F; Sönmez M; Ermantaş N; Özbaş HM; Cansız A; Balcı M; Yılmazz M
Gene; 2016 Jul; 586(2):263-7. PubMed ID: 27063556
[TBL] [Abstract][Full Text] [Related]
24. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
26. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
27. Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
Ann Oncol; 1997; 8 Suppl 2():59-63. PubMed ID: 9209643
[TBL] [Abstract][Full Text] [Related]
28. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
29. Metabolic gene variants and risk of non-Hodgkin's lymphoma.
De Roos AJ; Gold LS; Wang S; Hartge P; Cerhan JR; Cozen W; Yeager M; Chanock S; Rothman N; Severson RK
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1647-53. PubMed ID: 16985026
[TBL] [Abstract][Full Text] [Related]
30. L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma.
Taylor JA; Bell DA; Nagorney D
Int J Cancer; 1993 Jul; 54(6):927-30. PubMed ID: 8392982
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
32. 3' untranslated region A>C (rs3212227) polymorphism of Interleukin 12B gene as a potential risk factor for Hodgkin's lymphoma in Brazilian children and adolescents.
Silva OB; Correia NAA; de Barros FT; de Lima LPO; Morais A; Hassan R; Dellalibera E; de Mendonça Cavalcanti MDS; Muniz MTC
Tumour Biol; 2019 Jul; 41(7):1010428319860400. PubMed ID: 31277552
[TBL] [Abstract][Full Text] [Related]
33. Different susceptibility of each L-myc genotype to esophageal cancer risk factors.
Kumimoto H; Hamajima N; Nishizawa K; Nishimoto Y; Matsuo K; Harada H; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2001 Jul; 92(7):735-9. PubMed ID: 11473723
[TBL] [Abstract][Full Text] [Related]
34. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
35. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
36. Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.
Alexandrescu DT; Garino A; Brown-Balem KA; Wiernik PH
Leuk Lymphoma; 2006 Oct; 47(10):2115-27. PubMed ID: 17071485
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the bcl-2 gene in Hodgkin's disease.
Stetler-Stevenson M; Crush-Stanton S; Cossman J
J Natl Cancer Inst; 1990 May; 82(10):855-8. PubMed ID: 2185367
[TBL] [Abstract][Full Text] [Related]
38. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
[TBL] [Abstract][Full Text] [Related]
39. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
[No Abstract] [Full Text] [Related]
40. HLA class II polymorphism in Egyptian children with lymphomas.
Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]